Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer

NCT02548169 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped The study was stopped because of loss of funding and no safety issues

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: DC Vaccine + Standard of Care Chemotherapy

Sponsor

Baylor Research Institute